)
)
)
MedTech Under the Microscope: Regulation, Divisionals and NPE Litigation
The MedTech sector faces a unique convergence of IP and regulatory challenges, including the transition from the Medical Devices Directive (MDD) to the Medical Devices Regulation (MDR), increasingly complex divisional patent portfolios, growing non-practicing entity (NPE) activity and the evolving role of the UPC in European patent enforcement. This panel explores how medical device and diagnostics companies can align IP and regulatory strategy, manage enforcement risk, and navigate an increasingly complex European patent landscape.
- Understand how the transition from MDD to MDR is influencing IP strategy in the MedTech sector.
- Discuss the sector-specific challenges associated with patent density and divisional patent portfolios.
- Explore the rise of NPE activity and its impact on enforcement risk for MedTech companies.
- Assess the impact of the UPC on MedTech patent litigation landscape in Europe and globally.
